{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T18:55:47Z","timestamp":1791140147143,"version":"4.1.0"},"reference-count":145,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Narodowe Centrum Nauki,Poland","award":["2019\/35\/O\/NZ2\/03761"],"award-info":[{"award-number":["2019\/35\/O\/NZ2\/03761"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr. Treat. Options in Oncol."],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s11864-025-01348-y","type":"journal-article","created":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T05:32:32Z","timestamp":1759469552000},"page":"967-989","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Dermatofibrosarcoma Protuberans (DFSP): Current Treatments and Clinical Trials"],"prefix":"10.1007","volume":"26","author":[{"given":"Piotr","family":"Remiszewski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agata","family":"Pisklak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kinga","family":"Filipek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateusz J.","family":"Spa\u0142ek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Szumera -Cie\u0107kiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart\u0142omiej","family":"Szostakowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Krotewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna M.","family":"Czarnecka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,3]]},"reference":[{"key":"1348_CR1","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/j.jaad.2017.11.030","volume":"78","author":"O AQTrofymenko","year":"2018","unstructured":"AQTrofymenko O, Bordeaux JS, Zeitouni NC. Survival in patients with primary dermatofibrosarcoma protuberans: national cancer database analysis. J Am Acad Dermatol. 2018;78:1125\u201334.","journal-title":"J Am Acad Dermatol"},{"key":"1348_CR2","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1067\/j.cpradiol.2020.05.011","volume":"50","author":"B Mujtaba","year":"2021","unstructured":"Mujtaba B, Wang F, Taher A, Aslam R, Madewell JE, Spear R, Nassar S. Dermatofibrosarcoma protuberans: pathological and imaging review. Curr Probl Diagn Radiol. 2021;50:236\u201340.","journal-title":"Curr Probl Diagn Radiol"},{"key":"1348_CR3","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.jaad.2006.09.006","volume":"56","author":"VD Criscione","year":"2007","unstructured":"Criscione VD, Weinstock MA. Descriptive epidemiology of dermatofibrosarcoma protuberans in the United States, 1973 to 2002. J Am Acad Dermatol. 2007;56:968\u201373.","journal-title":"J Am Acad Dermatol"},{"key":"1348_CR4","doi-asserted-by":"publisher","first-page":"e1001","DOI":"10.1097\/MD.0000000000001001","volume":"94","author":"L Zhang","year":"2015","unstructured":"Zhang L, Liu Q, Cao Y, Zhong J, Zhang W. Dermatofibrosarcoma protuberans: computed tomography and magnetic resonance imaging findings. Med (Baltim). 2015;94:e1001.","journal-title":"Med (Baltim)"},{"key":"1348_CR5","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.1097\/DSS.0000000000000300","volume":"42","author":"KL Kreicher","year":"2016","unstructured":"Kreicher KL, Kurlander DE, Gittleman HR, Barnholtz-Sloan JS, Bordeaux JS. Incidence and survival of primary dermatofibrosarcoma protuberans in the United States. Dermatol Surg. 2016;42:S24-31.","journal-title":"Dermatol Surg"},{"key":"1348_CR6","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.3390\/jcm9061752","volume":"9","author":"X Hao","year":"2020","unstructured":"Hao X, Billings SD, Wu F, Stultz TW, Procop GW, Mirkin G, Vidimos AT. Dermatofibrosarcoma protuberans: update on the diagnosis and treatment. J Clin Med. 2020;9:1752.","journal-title":"J Clin Med"},{"key":"1348_CR7","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.det.2019.05.006","volume":"37","author":"A Allen","year":"2019","unstructured":"Allen A, Ahn C, Sang\u00fceza OP. Dermatofibrosarcoma protuberans. Dermatol Clin. 2019;37:483\u20138.","journal-title":"Dermatol Clin"},{"key":"1348_CR8","doi-asserted-by":"publisher","first-page":"2604","DOI":"10.1016\/j.ejca.2015.06.108","volume":"51","author":"P Saiag","year":"2015","unstructured":"Saiag P, Grob J-J, Lebbe C, Malvehy J, Del Marmol V, Pehamberger H, Peris K, Stratigos A, Middelton M, Basholt L. Diagnosis and treatment of dermatofibrosarcoma protuberans. European consensus-based interdisciplinary guideline. Eur J Cancer. 2015;51:2604\u20138.","journal-title":"Eur J Cancer"},{"issue":"5","key":"1348_CR9","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1097\/DSS.0000000000003411","volume":"48","author":"ECS Martin","year":"2022","unstructured":"Martin ECS, Vyas KS, Batbold S, Erwin PJ, Brewer JD. Dermatofibrosarcoma protuberans recurrence after wide local excision versus Mohs micrographic surgery: a systematic review and meta-analysis. Dermatol Surg. 2022;48(5):479\u201385.","journal-title":"Dermatol Surg"},{"key":"1348_CR10","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14954","volume":"34","author":"Y Chen","year":"2021","unstructured":"Chen Y, Jiang G. Association between surgical excision margins and outcomes in patients with dermatofibrosarcoma protuberans: a meta-analysis. Dermatol Ther. 2021;34: e14954.","journal-title":"Dermatol Ther"},{"key":"1348_CR11","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1016\/j.ejso.2017.03.011","volume":"43","author":"P Rutkowski","year":"2017","unstructured":"Rutkowski P, Klimczak A, \u0141ugowska I, Jagielska B, W\u0105grodzki M, D\u0119biec-Rychter M, Pie\u0144kowska-Grela B, \u015awitaj T. Long-term results of treatment of advanced dermatofibrosarcoma protuberans (DFSP) with imatinib mesylate\u2013the impact of fibrosarcomatous transformation. European Journal of Surgical Oncology (EJSO). 2017;43:1134\u201341.","journal-title":"European Journal of Surgical Oncology (EJSO)"},{"key":"1348_CR12","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1001\/archdermatol.2012.2685","volume":"148","author":"FO Zwald","year":"2012","unstructured":"Zwald FO. Underuse of Mohs micrographic surgery for the treatment of dermatofibrosarcoma protuberans: comment on efficacy of Mohs micrographic surgery for the treatment of dermatofibrosarcoma protuberans. Arch Dermatol. 2012;148:1064\u20131064.","journal-title":"Arch Dermatol"},{"key":"1348_CR13","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.jaad.2014.03.018","volume":"71","author":"CA Liang","year":"2014","unstructured":"Liang CA, Jambusaria-Pahlajani A, Karia PS, Elenitsas R, Zhang PD, Schmults CD. A systematic review of outcome data for dermatofibrosarcoma protuberans with and without fibrosarcomatous change. J Am Acad Dermatol. 2014;71:781\u20136.","journal-title":"J Am Acad Dermatol"},{"key":"1348_CR14","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1097\/00000478-199805000-00009","volume":"22","author":"T Mentzel","year":"1998","unstructured":"Mentzel T, Beham A, Katenkamp D, Dei Tos AP, Fletcher CD. Fibrosarcomatous (high-grade) dermatofibrosarcoma protuberans: clinicopathologic and immunohistochemical study of a series of 41 cases with emphasis on prognostic significance. Am J Surg Pathol. 1998;22:576\u201387.","journal-title":"Am J Surg Pathol"},{"key":"1348_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13014-019-1226-z","volume":"14","author":"K Du","year":"2019","unstructured":"Du K, Li J, Tang L, Lin X, Kong X, Liao X, Peng Q, Dong Y, He J, Huang Y. Role of postoperative radiotherapy in dermatofibrosarcoma protuberans: a propensity score-matched analysis. Radiat Oncol. 2019;14:1\u20138.","journal-title":"Radiat Oncol"},{"key":"1348_CR16","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1097\/DSS.0000000000002578","volume":"47","author":"C Jing","year":"2021","unstructured":"Jing C, Zhang H, Zhang X, Yu S. Dermatofibrosarcoma protuberans: a clinicopathologic and therapeutic analysis of 254 cases at a single institution. Dermatol Surg. 2021;47:e26\u201330.","journal-title":"Dermatol Surg"},{"key":"1348_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1758-3284-3-5","volume":"3","author":"N Angouridakis","year":"2011","unstructured":"Angouridakis N, Kafas P, Jerjes W, Triaridis S, Upile T, Karkavelas G, Nikolaou A. Dermatofibrosarcoma protuberans with fibrosarcomatous transformation of the head and neck. Head Neck Oncol. 2011;3:1\u20137.","journal-title":"Head Neck Oncol"},{"key":"1348_CR18","doi-asserted-by":"publisher","first-page":"3124","DOI":"10.3390\/cancers16183124","volume":"16","author":"M Jozwik","year":"2024","unstructured":"Jozwik M, Bednarczuk K, Osierda Z. Dermatofibrosarcoma protuberans: an updated review of the literature. Cancers. 2024;16:3124.","journal-title":"Cancers"},{"key":"1348_CR19","doi-asserted-by":"crossref","unstructured":"Hu M-Y, Kuo S-H. (2019) Adjuvant radiotherapy for dermatofibrosarcoma protuberans.","DOI":"10.21037\/tro.2019.08.01"},{"key":"1348_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12032-013-0765-7","volume":"30","author":"P Rutkowski","year":"2013","unstructured":"Rutkowski P, Andrzejuk J, Bylina E, Osuch C, \u015awitaj T, Jerzak vel Dobosz A, Grzesiakowska U, Jurkowska M, Wo\u017aniak A, Limon J. What are the current outcomes of advanced gastrointestinal stromal tumors: who are the long-term survivors treated initially with imatinib? Med Oncol. 2013;30:1\u201311.","journal-title":"Med Oncol"},{"key":"1348_CR21","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1001\/jamadermatol.2018.4940","volume":"155","author":"C Navarrete-Dechent","year":"2019","unstructured":"Navarrete-Dechent C, Mori S, Barker CA, Dickson MA, Nehal KS. Imatinib treatment for locally advanced or metastatic dermatofibrosarcoma protuberans: a systematic review. JAMA Dermatol. 2019;155:361\u20139.","journal-title":"JAMA Dermatol"},{"key":"1348_CR22","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1001\/jamadermatol.2016.1886","volume":"152","author":"MC Criscito","year":"2016","unstructured":"Criscito MC, Martires KJ, Stein JA. Prognostic factors, treatment, and survival in dermatofibrosarcoma protuberans. JAMA Dermatol. 2016;152:1365\u201371.","journal-title":"JAMA Dermatol"},{"key":"1348_CR23","doi-asserted-by":"publisher","first-page":"e773","DOI":"10.1097\/MD.0000000000000773","volume":"94","author":"C Wang","year":"2015","unstructured":"Wang C, Luo Z, Chen J, Zheng B, Zhang R, Chen Y, Shi Y. Target therapy of unresectable or metastatic dermatofibrosarcoma protuberans with Imatinib mesylate: an analysis on 22 Chinese patients. Med (Baltim). 2015;94:e773.","journal-title":"Med (Baltim)"},{"key":"1348_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2024.102475","author":"S Paramasivam","year":"2024","unstructured":"Paramasivam S, Rastogi S. 86P Advanced dermatofibrosarcoma protuberans (DFSP): experience from a sarcoma clinic in India with 38 patients. ESMO Open. 2024;9(Suppl 2):102475. https:\/\/doi.org\/10.1016\/j.esmoop.2024.102475.","journal-title":"ESMO Open"},{"key":"1348_CR25","first-page":"16","volume":"15","author":"K Shao","year":"2022","unstructured":"Shao K, Feng H. Racial and ethnic healthcare disparities in skin cancer in the United States: a review of existing inequities, contributing factors, and potential solutions. J Clin Aesthetic Dermatol. 2022;15:16.","journal-title":"J Clin Aesthetic Dermatol"},{"key":"1348_CR26","doi-asserted-by":"publisher","first-page":"3680","DOI":"10.1097\/JS9.0000000000001306","volume":"110","author":"Y Chen","year":"2024","unstructured":"Chen Y, Zhong N-N, Cao L-M, Liu B, Bu L-L. Surgical margins in head and neck squamous cell carcinoma: a narrative review. Int J Surg. 2024;110:3680\u2013700.","journal-title":"Int J Surg"},{"key":"1348_CR27","doi-asserted-by":"publisher","unstructured":"Chen S, Xiong L, Zhao L, Li Y, Li L. Survival outcomes and prognostic factors of dermatofibrosarcoma protuberans: a population-based retrospective cohort analysis. Dermatol Surg. 2023;49(9):825\u2013831. https:\/\/doi.org\/10.1097\/DSS.0000000000003853.","DOI":"10.1097\/DSS.0000000000003853"},{"key":"1348_CR28","doi-asserted-by":"publisher","first-page":"5442","DOI":"10.12998\/wjcc.v9.i20.5442","volume":"9","author":"J-X Xiong","year":"2021","unstructured":"Xiong J-X, Cai T, Hu L, Chen X-L, Huang K, Chen A-J, Wang P. Risk factors related to postoperative recurrence of dermatofibrosarcoma protuberans: a retrospective study and literature review. World J Clin Cases. 2021;9:5442.","journal-title":"World J Clin Cases"},{"key":"1348_CR29","doi-asserted-by":"crossref","unstructured":"van Huis F, Gr\u00fcnhagen DJ, Smith MJ, van Akkooi AC, Wouters MW, Hayes AJ, Verhoef C, Strauss DC, van Houdt WJ. (2019) Outcome after surgical treatment of dermatofibrosarcoma protuberans: Is clinical follow-up always indicated? Cancer 125:735\u2013741.","DOI":"10.1002\/cncr.31924"},{"key":"1348_CR30","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.bjps.2020.10.062","volume":"74","author":"A Gonz\u00e1lez","year":"2021","unstructured":"Gonz\u00e1lez A, Etchichury D, Rivero JM, Adamo L. Treatment of dermatofibrosarcoma of the head and neck with Mohs surgery with paraffin sections. J Plast Reconstr Aesthet Surg. 2021;74:1061\u201370.","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"1348_CR31","first-page":"104","volume":"1","author":"H Kose\u0142a","year":"2011","unstructured":"Kose\u0142a H, Rutkowski P. Dermatofibrosarcoma protuberans (DFSP)\u2013post\u0119py w diagnostyce i Leczeniu. OncoReview. 2011;1:104\u201311.","journal-title":"OncoReview"},{"key":"1348_CR32","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s10195-016-0415-x","volume":"17","author":"K Hayakawa","year":"2016","unstructured":"Hayakawa K, Matsumoto S, Ae K, Tanizawa T, Gokita T, Funauchi Y, Motoi N. Risk factors for distant metastasis of dermatofibrosarcoma protuberans. J Orthop Traumatol. 2016;17:261\u20136.","journal-title":"J Orthop Traumatol"},{"key":"1348_CR33","doi-asserted-by":"publisher","DOI":"10.21037\/atm.2019.02.20","author":"H Chen","year":"2019","unstructured":"Chen H, Liu Y, Peng F, et al. Pulmonary metastases of fibrosarcomatous dermatofibrosarcoma protuberans respond to apatinib-based angiogenesis and chemotherapy: a case report. Ann Transl Med. 2019;7(7):149. https:\/\/doi.org\/10.21037\/atm.2019.02.20.","journal-title":"Ann Transl Med"},{"key":"1348_CR34","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.jaad.2012.01.039","volume":"67","author":"IIDW Buck","year":"2012","unstructured":"Buck IIDW, Kim JY, Alam M, Rawlani V, Johnson S, Connor CM, Dumanian GA, Wayne JD. Multidisciplinary approach to the management of dermatofibrosarcoma protuberans. J Am Acad Dermatol. 2012;67:861\u20136.","journal-title":"J Am Acad Dermatol"},{"key":"1348_CR35","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1097\/PAS.0b013e3181cf7fc1","volume":"34","author":"M Edelweiss","year":"2010","unstructured":"Edelweiss M, Malpica A. Dermatofibrosarcoma protuberans of the vulva: a clinicopathologic and immunohistochemical study of 13 cases. Am J Surg Pathol. 2010;34:393\u2013400.","journal-title":"Am J Surg Pathol"},{"key":"1348_CR36","doi-asserted-by":"publisher","unstructured":"Muto Y, Fujimura T, Takahashi A, Namikawa K, Ogata D, Nakano E, Jinnai S, Hashimoto A, Kambayashi Y, Asano Y. Analysis of surgical margins and prognostic factors in dermatofibrosarcoma protuberans after wide local excision: a multicenter study of 116 Japanese patients. J Dermatol. 2024(9). https:\/\/doi.org\/10.1111\/1346-8138.17280.","DOI":"10.1111\/1346-8138.17280"},{"key":"1348_CR37","doi-asserted-by":"publisher","unstructured":"Gassenmaier M, Weber E, Leiter U, Hahn M, Forchhammer S, H\u00e4fner H-M, Scheu A, Garbe C, Schnabl SM. Micrographic surgery allows fascia preservation in dermatofibrosarcoma protuberans. Acta Derm Venereol. 2021;101(9):adv00561. https:\/\/doi.org\/10.2340\/00015555-3915.","DOI":"10.2340\/00015555-3915"},{"key":"1348_CR38","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1007\/s13193-022-01636-1","volume":"14","author":"S Mani","year":"2023","unstructured":"Mani S, Kumar R, Kakkar A, Barwad A, Dheeraj K, Sagar P, Kumar R. Recurrent dermatofibrosarcoma protuberans of the head and neck: a case series. Indian J Surg Oncol. 2023;14:128\u201336.","journal-title":"Indian J Surg Oncol"},{"key":"1348_CR39","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/S0190-9622(97)70179-8","volume":"37","author":"D Ratner","year":"1997","unstructured":"Ratner D, Thomas CO, Johnson TM, Sondak VK, Hamilton TA, Nelson BR, Swanson NA, Garcia C, Clark RE, Grande DJ. Mohs micrographic surgery for the treatment of dermatofibrosarcoma protuberans: results of a multiinstitutional series with an analysis of the extent of microscopic spread. J Am Acad Dermatol. 1997;37:600\u201313.","journal-title":"J Am Acad Dermatol"},{"key":"1348_CR40","doi-asserted-by":"crossref","unstructured":"Kim BJ, Kim H, Jin US, Minn KW, Chang H. (2015) Wide local excision for dermatofibrosarcoma protuberans: a single-center series of 90 patients. BioMed Res Int 2015:642549.","DOI":"10.1155\/2015\/642549"},{"key":"1348_CR41","doi-asserted-by":"publisher","first-page":"2295816","DOI":"10.1080\/09546634.2023.2295816","volume":"35","author":"A Sanabria","year":"2024","unstructured":"Sanabria A, Pinillos P, Chiesa-Estomba C, Guntinas-Lichius O, Kowalski LP, M\u00e4kitie AA, Rao KN, Ferlito A. Comparing Mohs micrographic surgery and wide local excision in the management of head and neck dermatofibrosarcoma protuberans: a scoping review. J Dermatol Treat. 2024;35:2295816.","journal-title":"J Dermatol Treat"},{"key":"1348_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10434-000-0001-5","volume":"7","author":"JP Richie","year":"2000","unstructured":"Richie JP. Urinary diversion: the patient\u2019s choice. Ann Surg Oncol. 2000;7:1\u20131.","journal-title":"Ann Surg Oncol"},{"key":"1348_CR43","doi-asserted-by":"publisher","unstructured":"Malan M, Xuejingzi W, Quan SJ. The efficacy of Mohs micrographic surgery over the traditional wide local excision surgery in the cure of dermatofibrosarcoma protuberans. Pan Afr Med J. 2019;33:297. https:\/\/doi.org\/10.11604\/pamj.2019.33.297.17692.","DOI":"10.11604\/pamj.2019.33.297.17692"},{"key":"1348_CR44","doi-asserted-by":"crossref","unstructured":"Gloster HM Jr. Dermatofibrosarcoma protuberans. J Am Acad Dermatol. 1996;35:355\u201374.","DOI":"10.1016\/S0190-9622(96)90597-6"},{"key":"1348_CR45","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.soc.2016.05.011","volume":"25","author":"JT Mullen","year":"2016","unstructured":"Mullen JT. Dermatofibrosarcoma protuberans: wide local excision versus Mohs micrographic surgery. Surg Oncol Clin. 2016;25:827\u201339.","journal-title":"Surg Oncol Clin"},{"key":"1348_CR46","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1001\/archdermatol.2012.1440","volume":"148","author":"M Foroozan","year":"2012","unstructured":"Foroozan M, Sei J-F, Amini M, Beauchet A, Saiag P. Efficacy of Mohs micrographic surgery for the treatment of dermatofibrosarcoma protuberans: systematic review. Arch Dermatol. 2012;148:1055\u201363.","journal-title":"Arch Dermatol"},{"key":"1348_CR47","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.jaad.2012.03.034","volume":"67","author":"I Irarrazaval","year":"2012","unstructured":"Irarrazaval I, Redondo P. Three-dimensional histology for dermatofibrosarcoma protuberans: case series and surgical technique. J Am Acad Dermatol. 2012;67:991\u20136.","journal-title":"J Am Acad Dermatol"},{"key":"1348_CR48","doi-asserted-by":"publisher","DOI":"10.1177\/20363613221123951","volume":"14","author":"V Mago","year":"2022","unstructured":"Mago V, Pasricha A. Reconstruction options in recurrent dermatofibrosarcoma protuberans: a scoping review. Rare Tumors. 2022;14: 20363613221123951.","journal-title":"Rare Tumors"},{"key":"1348_CR49","doi-asserted-by":"crossref","unstructured":"Besharah BO, Ghazzawi RA, Al-Kaff HH, Abdelmonim SK, Al-Essa MA. (2020) Reconstruction of facial dermatofibrosarcoma protuberans using an anterolateral thigh flap: a case report and literature review. J Surg Case Rep 2020:rjaa340.","DOI":"10.1093\/jscr\/rjaa340"},{"key":"1348_CR50","doi-asserted-by":"publisher","first-page":"e597","DOI":"10.1097\/SCS.0b013e3182a238c1","volume":"24","author":"B Longo","year":"2013","unstructured":"Longo B, Paolini G, Belli E, Costantino B, Pagnoni M, Santanelli F. Wide excision and anterolateral thigh perforator flap reconstruction for dermatofibrosarcoma protuberans of the face. J Craniofac Surg. 2013;24:e597\u20139.","journal-title":"J Craniofac Surg"},{"key":"1348_CR51","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1177\/230949900201000217","volume":"10","author":"Y Taniguchi","year":"2002","unstructured":"Taniguchi Y, Tamaki T, Yoshida M, Uematsu Y. Reconstruction of a scalp and skull defect with free latissimus dorsi myocutaneous flap following dermatofibrosarcoma protuberans. J Orthop Surg. 2002;10:206\u20139.","journal-title":"J Orthop Surg"},{"key":"1348_CR52","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1055\/s-0033-1343832","volume":"29","author":"KG Teo","year":"2013","unstructured":"Teo KG, Rozen WM, Acosta R. The pectoralis major myocutaneous flap. J Reconstr Microsurg. 2013;29:449\u201356.","journal-title":"J Reconstr Microsurg"},{"key":"1348_CR53","doi-asserted-by":"publisher","first-page":"37","DOI":"10.4103\/0975-5950.168225","volume":"6","author":"M Tripathi","year":"2015","unstructured":"Tripathi M, Parshad S, Karwasra RK, Singh V. Pectoralis major myocutaneous flap in head and neck reconstruction: an experience in 100 consecutive cases. Natl J Maxillofac Surg. 2015;6:37\u201341.","journal-title":"Natl J Maxillofac Surg"},{"key":"1348_CR54","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/j.1468-3083.2008.02672.x","volume":"23","author":"F Trindade","year":"2008","unstructured":"Trindade F, Rosa J. Vertical rectus abdominis myocutaneous flap in the treatment of a recurrent dermatofibrosarcoma protuberans. J Eur Acad Dermatol Venereol JEADV. 2008;23:75\u20136.","journal-title":"J Eur Acad Dermatol Venereol JEADV"},{"key":"1348_CR55","doi-asserted-by":"crossref","unstructured":"Sakamoto A, Noguchi T, Matsuda S. (2021) Thoracoabdominal flap reconstruction after resection of superficial soft-tissue sarcomas in the chest wall. J Surg Case Rep 2021:rjaa571.","DOI":"10.1093\/jscr\/rjaa571"},{"key":"1348_CR56","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1097\/MOO.0b013e328347f811","volume":"19","author":"RJ Kim","year":"2011","unstructured":"Kim RJ, Izzard ME, Patel RS. Supraclavicular artery island flap for reconstructing defects in the head and neck region. Curr Opin Otolaryngol Head Neck Surg. 2011;19:248\u201350.","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"1348_CR57","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1001\/jamaoto.2013.5057","volume":"139","author":"N Kokot","year":"2013","unstructured":"Kokot N, Mazhar K, Reder LS, Peng GL, Sinha UK. The supraclavicular artery Island flap in head and neck reconstruction: applications and limitations. JAMA Otolaryngol Neck Surg. 2013;139:1247\u201355.","journal-title":"JAMA Otolaryngol Neck Surg"},{"key":"1348_CR58","doi-asserted-by":"publisher","unstructured":"Yi L, Jimeno ZKL, Ramesh A, Sasidaran R, Feng PA, Lah NASN. A challenge in soft tissue reconstruction: the use of pedicled anterolateral thigh fasciocutaneous flap and gluteal fasciocutaneous rotational flap in reconstructing a huge full thickness lateral trunk defect. Ann Med Surg (Lond). 2021;71:102933. https:\/\/doi.org\/10.1016\/j.amsu.2021.102933.","DOI":"10.1016\/j.amsu.2021.102933"},{"key":"1348_CR59","doi-asserted-by":"publisher","unstructured":"Brahmachari S, Pandey A, Singh MP, Agarwal V, Bramhachari S, Singh M. An integrated surgical management for giant dermatofibrosarcoma protuberans of anterior abdominal wall. Cureus. 2021;13(8):e17038. https:\/\/doi.org\/10.7759\/cureus.17038.","DOI":"10.7759\/cureus.17038"},{"key":"1348_CR60","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1245\/s10434-006-9233-3","volume":"14","author":"Z Kimmel","year":"2007","unstructured":"Kimmel Z, Ratner D, Kim JY, Wayne JD, Rademaker AW, Alam M. Peripheral excision margins for dermatofibrosarcoma protuberans: a meta-analysis of spatial data. Ann Surg Oncol. 2007;14:2113\u201320.","journal-title":"Ann Surg Oncol"},{"key":"1348_CR61","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1002\/cncr.20051","volume":"100","author":"D DuBay","year":"2004","unstructured":"DuBay D, Cimmino V, Lowe L, Johnson TM, Sondak VK. Low recurrence rate after surgery for dermatofibrosarcoma protuberans: a multidisciplinary approach from a single institution. Cancer. 2004;100:1008\u201316.","journal-title":"Cancer"},{"key":"1348_CR62","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.ejso.2020.06.022","volume":"47","author":"E Huis","year":"2021","unstructured":"Huis E, Gr\u00fcnhagen D, Van Coevorden F, Smith M, van Akkooi A, Wouters M, Verhoef C, Strauss D, Hayes A, van Houdt W. Adequate surgical margins for dermatofibrosarcoma protuberans\u2013A multi-centre analysis. Eur J Surg Oncol. 2021;47:436\u201342.","journal-title":"Eur J Surg Oncol"},{"key":"1348_CR63","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1016\/j.annonc.2021.07.006","volume":"32","author":"A Gronchi","year":"2021","unstructured":"Gronchi A, Miah A, Dei Tos A, Abecassis N, Bajpai J, Bauer S, Biagini R, Bielack S, Blay J, Bolle S. Soft tissue and visceral sarcomas: ESMO\u2013EURACAN\u2013GENTURIS clinical practice guidelines for diagnosis, treatment and follow-up\u2606. Ann Oncol. 2021;32:1348\u201365.","journal-title":"Ann Oncol"},{"key":"1348_CR64","unstructured":"National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology. Httpwww Nccn OrgprofessionalsphysicianglsPDFoccult Pdf; 2008."},{"key":"1348_CR65","doi-asserted-by":"crossref","unstructured":"Fionda B, Loperfido A, Di Stefani A, Lancellotta V, Paradisi A, De Angeli M, Cappilli S, Rossi E, Caretto AA, Zinicola T. The Role of Postoperative Radiotherapy in the Management of Dermatofibrosarcoma Protuberans: A Multidisciplinary Systematic Review. J Clin Med. 2024;13:1798.","DOI":"10.3390\/jcm13061798"},{"key":"1348_CR66","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/0360-3016(89)90454-9","volume":"17","author":"LB Marks","year":"1989","unstructured":"Marks LB, Suit HD, Rosenberg AE, Wood WC. Dermatofibrosarcoma protuberans treated with radiation therapy. Int J Radiat Oncol Biol Phys. 1989;17:379\u201384.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1348_CR67","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1200\/JCO.1996.14.8.2365","volume":"14","author":"H Suit","year":"1996","unstructured":"Suit H, Spiro I, Mankin HJ, Efird J, Rosenberg A. Radiation in management of patients with dermatofibrosarcoma protuberans. J Clin Oncol. 1996;14:2365\u20139.","journal-title":"J Clin Oncol"},{"key":"1348_CR68","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/S0360-3016(97)00895-X","volume":"40","author":"MT Ballo","year":"1998","unstructured":"Ballo MT, Zagars GK, Pisters P, Alan Pollack M. The role of radiation therapy in the management of dermatofibrosarcoma protuberans. Int J Radiat Oncol Biol Phys. 1998;40:823\u20137.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1348_CR69","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.ijrobp.2013.02.024","volume":"86","author":"KO Castle","year":"2013","unstructured":"Castle KO, Guadagnolo BA, Tsai CJ, Feig BW, Zagars GK. Dermatofibrosarcoma protuberans: long-term outcomes of 53 patients treated with conservative surgery and radiation therapy. Int J Radiat Oncol Biol Phys. 2013;86:585\u201390.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1348_CR70","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1001\/archotol.1993.01880200097014","volume":"119","author":"RJ Mark","year":"1993","unstructured":"Mark RJ, Bailet JW, Tran LM, Poen J, Fu YS, Calcaterra TC. Dermatofibrosarcoma protuberans of the head and neck: a report of 16 cases. Arch Otolaryngol Neck Surg. 1993;119:891\u20136.","journal-title":"Arch Otolaryngol Neck Surg"},{"key":"1348_CR71","first-page":"268","volume":"18","author":"B Uysal","year":"2013","unstructured":"Uysal B, Sager O, Gamsiz H, Cicek A, Demiral S, Dincoglan F, Surenkok S, Demiriz M, Beyzadeoglu M. Evaluation of the role of radiotherapy in the management of dermatofibrosarcoma protuberans. J BUON. 2013;18:268\u201373.","journal-title":"J BUON"},{"key":"1348_CR72","doi-asserted-by":"publisher","first-page":"232","DOI":"10.4103\/2278-330x.119926","volume":"2","author":"R Hamid","year":"2013","unstructured":"Hamid R, Hafeez A, Darzi AM, Zaroo I, Owais H, Akhter A. Dermatofibrosarcoma protuberans: role of wide local excision. South Asian J Cancer. 2013;2:232\u20138.","journal-title":"South Asian J Cancer"},{"key":"1348_CR73","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1097\/COC.0b013e31827dee86","volume":"37","author":"N Williams","year":"2014","unstructured":"Williams N, Morris CG, Kirwan JM, Dagan R, Mendenhall WM. Radiotherapy for dermatofibrosarcoma protuberans. Am J Clin Oncol. 2014;37:430\u20132.","journal-title":"Am J Clin Oncol"},{"key":"1348_CR74","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.ad.2018.05.006","volume":"109","author":"B Llombart","year":"2018","unstructured":"Llombart B, Serra C, Requena C, Alsina M, Morgado-Carrasco D, Trav\u00e9s V, Sanmart\u00edn O. Guidelines for diagnosis and treatment of cutaneous sarcomas: dermatofibrosarcoma protuberans. Actas Dermo-Sifiliogr\u00e1ficas Engl Ed. 2018;109:868\u201377.","journal-title":"Actas Dermo-Sifiliogr\u00e1ficas Engl Ed"},{"key":"1348_CR75","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-024-02674-y","author":"AJ Hayes","year":"2024","unstructured":"Hayes AJ, Nixon IF, Strauss DC, Seddon BM, Desai A, Benson C, Judson IR, Dangoor A. UK guidelines for the management of soft tissue sarcomas. Br J Cancer. 2024. https:\/\/doi.org\/10.1038\/s41416-024-02674-y.","journal-title":"Br J Cancer"},{"key":"1348_CR76","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1097\/DAD.0000000000000584","volume":"39","author":"MYO Abdaljaleel","year":"2017","unstructured":"Abdaljaleel MYO, North JP. Sclerosing dermatofibrosarcoma protuberans shows significant overlap with sclerotic fibroma in both routine and immunohistochemical analysis: a potential diagnostic pitfall. Am J Dermatopathol. 2017;39:83\u20138.","journal-title":"Am J Dermatopathol"},{"key":"1348_CR77","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1016\/S0022-3468(98)90292-5","volume":"33","author":"JR Marcus","year":"1998","unstructured":"Marcus JR, Few JW, Senger C, Reynolds M. Dermatofibrosarcoma protuberans and the Bednar tumor: treatment in the pediatric population. J Pediatr Surg. 1998;33:1811\u20134.","journal-title":"J Pediatr Surg"},{"key":"1348_CR78","doi-asserted-by":"publisher","unstructured":"Huber GF, Matthews TW, Dort JC. Radiation-induced soft tissue sarcomas of the head and neck. J Otolaryngol. 2007;36(2):93-97. https:\/\/doi.org\/10.2310\/7070.2007.0001.","DOI":"10.2310\/7070.2007.0001"},{"key":"1348_CR79","first-page":"81","volume":"53","author":"C Socoliuc","year":"2015","unstructured":"Socoliuc C, Zurac S, Andrei R, St\u0103niceanu F. Multiple histological subtypes of dermatofibrosarcoma protuberans occurring in the same tumor. Rom J Intern Med. 2015;53:81\u201390.","journal-title":"Rom J Intern Med"},{"key":"1348_CR80","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.humpath.2010.07.015","volume":"42","author":"S Segura","year":"2011","unstructured":"Segura S, Salgado R, Toll A, Mart\u00edn-Ezquerra G, Y\u00e9benes M, S\u00e1ez A, Sol\u00e9 F, Barranco C, Umbert P, Espinet B. Identification of t (17; 22)(q22; q13)(COL1A1\/PDGFB) in dermatofibrosarcoma protuberans by fluorescence in situ hybridization in paraffin-embedded tissue microarrays. Hum Pathol. 2011;42:176\u201384.","journal-title":"Hum Pathol"},{"key":"1348_CR81","first-page":"357027","volume":"2014","author":"N Iqbal","year":"2014","unstructured":"Iqbal N, Iqbal N. Imatinib: a breakthrough of targeted therapy in cancer. Chemother Res Pract. 2014;2014:357027.","journal-title":"Chemother Res Pract"},{"key":"1348_CR82","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41392-022-01168-8","volume":"7","author":"Y Yang","year":"2022","unstructured":"Yang Y, Li S, Wang Y, Zhao Y, Li Q. Protein tyrosine kinase inhibitor resistance in malignant tumors: molecular mechanisms and future perspective. Signal Transduct Target Ther. 2022;7:329.","journal-title":"Signal Transduct Target Ther"},{"key":"1348_CR83","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1399486","volume":"14","author":"Z Meng","year":"2024","unstructured":"Meng Z, Zhang R, Sun Z, Fu C, Li Z, Wang L, Huo R, Xue F. Hotspots and future trends of dermatofibrosarcoma protuberans. Front Oncol. 2024;14: 1399486.","journal-title":"Front Oncol"},{"key":"1348_CR84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2045-3329-3-5","volume":"3","author":"FG Kamar","year":"2013","unstructured":"Kamar FG, Kairouz VF, Sabri AN. Dermatofibrosarcoma protuberans (DFSP) successfully treated with sorafenib: case report. Clin Sarcoma Res. 2013;3:1\u20135.","journal-title":"Clin Sarcoma Res"},{"key":"1348_CR85","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1080\/14737140.2024.2384584","volume":"24","author":"S Radaelli","year":"2024","unstructured":"Radaelli S, Merlini A, Khan M, Gronchi A. Progress in histology specific treatments in soft tissue sarcoma. Expert Rev Anticancer Ther. 2024;24:845\u201368.","journal-title":"Expert Rev Anticancer Ther"},{"key":"1348_CR86","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1111\/1346-8138.13717","volume":"44","author":"T Miyagawa","year":"2017","unstructured":"Miyagawa T, Kadono T, Kimura T, Saigusa R, Yoshizaki A, Miyagaki T, Yamada D, Masui Y, Fujita H, Sato S. Pazopanib induced a partial response in a patient with metastatic fibrosarcomatous dermatofibrosarcoma protuberans without genetic translocations resistant to mesna, doxorubicin, Ifosfamide and Dacarbazine chemotherapy and gemcitabine-docetaxel chemotherapy. J Dermatol. 2017;44:e21\u20132.","journal-title":"J Dermatol"},{"key":"1348_CR87","doi-asserted-by":"publisher","first-page":"2952","DOI":"10.1002\/cncr.30191","volume":"122","author":"R Ratan","year":"2016","unstructured":"Ratan R, Patel SR. Chemotherapy for soft tissue sarcoma. Cancer. 2016;122:2952\u201360.","journal-title":"Cancer"},{"key":"1348_CR88","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1199292","volume":"14","author":"Z Tian","year":"2023","unstructured":"Tian Z, Yao W. Chemotherapeutic drugs for soft tissue sarcomas: a review. Front Pharmacol. 2023;14: 1199292.","journal-title":"Front Pharmacol"},{"key":"1348_CR89","doi-asserted-by":"crossref","unstructured":"Gupta A, Rastogi S, Kumar CS, Barwad A, Dhamija E, Panday R, Deo S, Shishak S, Aggarwal A, Dutta R. Systemic therapy in advanced dermatofibrosarcoma protuberans. Imatinib and beyond; 2019.","DOI":"10.1200\/JCO.2019.37.15_suppl.e22523"},{"key":"1348_CR90","first-page":"239","volume":"52","author":"C Socoliuc","year":"2014","unstructured":"Socoliuc C, Zurac S, Andrei R, St\u0103niceanu F. A review of morphological aspects in dermatofibrosarcoma protuberans with clinicopathological correlations. Rom J Intern Med Rev Roum Med Interne. 2014;52:239\u201350.","journal-title":"Rom J Intern Med Rev Roum Med Interne"},{"key":"1348_CR91","first-page":"17","volume":"4","author":"GK Kim","year":"2011","unstructured":"Kim GK. Status report on the management of dermatofibrosarcoma protuberans: is there a viable role for the use of Imatinib mesylate? In which cases may it be therapeutically helpful and in which cases not? J Clin Aesthetic Dermatol. 2011;4:17.","journal-title":"J Clin Aesthetic Dermatol"},{"key":"1348_CR92","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.jdcr.2020.07.053","volume":"6","author":"AT Reid","year":"2020","unstructured":"Reid AT, Berger A, Johnson-Jahangir H. Dermatofibrosarcoma protuberans with fibrosarcomatous transformation: a Tale of unbridled expansion. JAAD Case Rep. 2020;6:1006\u20138.","journal-title":"JAAD Case Rep"},{"key":"1348_CR93","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1093\/ced\/llac111","volume":"48","author":"SX Lim","year":"2023","unstructured":"Lim SX, Ramaiya A, Levell NJ, Venables ZC. Review of dermatofibrosarcoma protuberans. Clin Exp Dermatol. 2023;48:297\u2013302.","journal-title":"Clin Exp Dermatol"},{"key":"1348_CR94","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1158\/1541-7786.MCR-16-0068","volume":"14","author":"S Stacchiotti","year":"2016","unstructured":"Stacchiotti S, Astolfi A, Gronchi A, Fontana A, Pantaleo MA, Negri T, Brenca M, Tazzari M, Urbini M, Indio V. Evolution of dermatofibrosarcoma protuberans to DFSP-derived fibrosarcoma: an event marked by epithelial\u2013mesenchymal transition\u2013like process and 22q loss. Mol Cancer Res. 2016;14:820\u20139.","journal-title":"Mol Cancer Res"},{"key":"1348_CR95","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.1002\/1097-0142(20000615)88:12<2711::AID-CNCR9>3.0.CO;2-M","volume":"88","author":"WB Bowne","year":"2000","unstructured":"Bowne WB, Antonescu CR, Leung DH, Katz SC, Hawkins WG, Woodruff JM, Brennan MF, Lewis JJ. Dermatofibrosarcoma protuberans: a clinicopathologic analysis of patients treated and followed at a single institution. Cancer. 2000;88:2711\u201320.","journal-title":"Cancer"},{"key":"1348_CR96","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1111\/cup.14148","volume":"49","author":"K Campbell","year":"2022","unstructured":"Campbell K, Bridge JA, DiMaio D, Wilson J, Shalin SC, Gardner JM. Dermatofibrosarcoma protuberans with platelet-derived growth factor\u2010D rearrangement; two cases with morphologically distinct presentations. J Cutan Pathol. 2022;49:274\u20137.","journal-title":"J Cutan Pathol"},{"key":"1348_CR97","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1111\/j.1468-3083.2011.04141.x","volume":"25","author":"H Voth","year":"2011","unstructured":"Voth H, Landsberg J, Hinz T, Wenzel J, Bieber T, Reinhard G, H\u00f6ller T, Wendtner C, Schmid-Wendtner M. Management of dermatofibrosarcoma protuberans with fibrosarcomatous transformation: an evidence\u2010based review of the literature. J Eur Acad Dermatol Venereol. 2011;25:1385\u201391.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1348_CR98","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1097\/00000478-198509000-00002","volume":"9","author":"W Dupree","year":"1985","unstructured":"Dupree W, Langloss J, Weiss S. Pigmented dermatofibrosarcoma protuberans (Bednar tumor): a pathologic, ultrastructural, and immunohistochemical study a pathologic, ultrastructural, and immunohistochemical study. Am J Surg Pathol. 1985;9:630\u20139.","journal-title":"Am J Surg Pathol"},{"key":"1348_CR99","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/j.0303-6987.2005.320au.x","volume":"32","author":"J Chu McAllister","year":"2005","unstructured":"Chu McAllister J, Sundram U. CD34\u2009+ pigmented fibrous proliferations: the morphologic overlap between pigmented dermatofibromas and Bednar tumors. J Cutan Pathol. 2005;32:82\u201382.","journal-title":"J Cutan Pathol"},{"key":"1348_CR100","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.3390\/cancers13092224","volume":"13","author":"J Beaziz","year":"2021","unstructured":"Beaziz J, Battistella M, Delyon J, Farges C, Marco O, Pages C, Le Maignan C, Da Meda L, Basset-Seguin N, Resche-Rigon M. Long-term outcome of neoadjuvant tyrosine kinase inhibitors followed by complete surgery in locally advanced dermatofibrosarcoma protuberans. Cancers. 2021;13:2224.","journal-title":"Cancers"},{"key":"1348_CR101","first-page":"497148","volume":"2011","author":"J Nishio","year":"2011","unstructured":"Nishio J, Iwasaki H, Nabeshima K, Naito M. Cytogenetics and molecular genetics of myxoid soft-tissue sarcomas. Genet Res Int. 2011;2011:497148.","journal-title":"Genet Res Int"},{"key":"1348_CR102","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1097\/DAD.0b013e318145413c","volume":"29","author":"T Mentzel","year":"2007","unstructured":"Mentzel T, Sch\u00e4rer L, Kazakov DV, Michal M. Myxoid dermatofibrosarcoma protuberans: clinicopathologic, immunohistochemical, and molecular analysis of eight cases. Am J Dermatopathol. 2007;29:443\u20138.","journal-title":"Am J Dermatopathol"},{"key":"1348_CR103","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1097\/00000478-198307000-00007","volume":"7","author":"HF Frierson","year":"1983","unstructured":"Frierson HF, Cooper PH. Myxoid variant of dermatofibrosarcoma protuberans. Am J Surg Pathol. 1983;7:445\u201350.","journal-title":"Am J Surg Pathol"},{"key":"1348_CR104","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3315\/jdcr.2012.1089","volume":"6","author":"O Bakry","year":"2012","unstructured":"Bakry O, Attia A. Atrophic dermatofibrosarcoma protuberans. J Dermatol Case Rep. 2012;6:14.","journal-title":"J Dermatol Case Rep"},{"key":"1348_CR105","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.pathol.2019.06.002","volume":"51","author":"S Xu","year":"2019","unstructured":"Xu S, Zhao L, Wang J. Atrophic dermatofibrosarcoma protuberans: a clinicopathological study of 16 cases. Pathology. 2019;51:615\u201320.","journal-title":"Pathology"},{"key":"1348_CR106","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/j.1365-4632.2004.02340.x","volume":"45","author":"V Sabater-Marco","year":"2006","unstructured":"Sabater-Marco V, P\u00e9rez\u2010Vall\u00e9s A, Berzal\u2010Cantalejo F, Rodriguez\u2010Serna M, Martinez\u2010Diaz F, Martorell\u2010Cebollada M. Sclerosing dermatofibrosarcoma protuberans (DFSP): an unusual variant with focus on the histopathologic differential diagnosis. Int J Dermatol. 2006;45:59\u201362.","journal-title":"Int J Dermatol"},{"key":"1348_CR107","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1046\/j.1365-2133.2003.05185.x","volume":"148","author":"H Hattori","year":"2003","unstructured":"Hattori H. Nodular sclerotic change in dermatofibrosarcoma protuberans: a potential diagnostic problem. Br J Dermatol. 2003;148:357\u201360.","journal-title":"Br J Dermatol"},{"key":"1348_CR108","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.anndiagpath.2006.12.010","volume":"11","author":"P Jha","year":"2007","unstructured":"Jha P, Moosavi C, Fanburg-Smith JC. Giant cell fibroblastoma: an update and addition of 86 new cases from the armed forces Institute of pathology, in honor of dr. Franz M. Enzinger. Ann Diagn Pathol. 2007;11:81\u20138.","journal-title":"Ann Diagn Pathol"},{"key":"1348_CR109","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1002\/dc.10123","volume":"26","author":"LJ Layfield","year":"2002","unstructured":"Layfield LJ, Gopez EV. Fine-needle aspiration cytology of giant cell fibroblastoma: case report and review of the literature. Diagn Cytopathol. 2002;26:398\u2013403.","journal-title":"Diagn Cytopathol"},{"key":"1348_CR110","doi-asserted-by":"publisher","first-page":"e2021368","DOI":"10.4322\/acr.2021.368","volume":"12","author":"C Lo","year":"2022","unstructured":"Lo C, Tsang P, Cheng S. Myoid differentiation in dermatofibrosarcoma protuberans and its fibrosarcomatous variant: 10 years\u2019 experience in a tertiary hospital. Autopsy Case Rep. 2022;12:e2021368.","journal-title":"Autopsy Case Rep"},{"key":"1348_CR111","doi-asserted-by":"publisher","first-page":"e228","DOI":"10.18295\/squmj.2018.18.02.019","volume":"18","author":"S Yadav","year":"2018","unstructured":"Yadav S, Verma N, Khurana N, Neogi S. Recurrent dermatofibrosarcoma protuberans with pigmentation and myoid differentiation. Sultan Qaboos Univ Med J. 2018;18:e228.","journal-title":"Sultan Qaboos Univ Med J"},{"key":"1348_CR112","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/j.0303-6987.2006.0511h.x","volume":"33","author":"P Saadat","year":"2006","unstructured":"Saadat P, Vadmal M. Granular cell variant of dermatofibrosarcoma protuberans (DFSP). J Cutan Pathol. 2006;33:67\u201367.","journal-title":"J Cutan Pathol"},{"key":"1348_CR113","first-page":"375","volume":"12","author":"J Noujaim","year":"2015","unstructured":"Noujaim J, Thway K, Fisher C, Jones RL. Dermatofibrosarcoma protuberans: from translocation to targeted therapy. Cancer Biol Med. 2015;12:375.","journal-title":"Cancer Biol Med"},{"key":"1348_CR114","doi-asserted-by":"publisher","unstructured":"Kurimoto T, Mitsui Y, Nakanishi T, Morita K, Ishida E, Ogawa K, Koga K, Fukumoto T, Asada H. Sclerosing dermatofibrosarcoma protuberans: a possible diagnosis when a small biopsy shows sclerotic fibroma-like features. Am J Dermatopathol. 2024;46(10):675\u2013678. https:\/\/doi.org\/10.1097\/DAD.0000000000002773.","DOI":"10.1097\/DAD.0000000000002773"},{"key":"1348_CR115","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1097\/PAS.0b013e31802ff7e7","volume":"31","author":"JD Reimann","year":"2007","unstructured":"Reimann JD, Fletcher CD. Myxoid dermatofibrosarcoma protuberans: a rare variant analyzed in a series of 23 cases. Am J Surg Pathol. 2007;31:1371\u20137.","journal-title":"Am J Surg Pathol"},{"key":"1348_CR116","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1245\/s10434-010-1316-5","volume":"18","author":"RC Fields","year":"2011","unstructured":"Fields RC, Hameed M, Qin L-X, Moraco N, Jia X, Maki RG, Singer S, Brennan MF. Dermatofibrosarcoma protuberans (DFSP): predictors of recurrence and the use of systemic therapy. Ann Surg Oncol. 2011;18:328\u201336.","journal-title":"Ann Surg Oncol"},{"key":"1348_CR117","doi-asserted-by":"publisher","first-page":"e254473","DOI":"10.1136\/bcr-2022-254473","volume":"16","author":"A Agarwal","year":"2023","unstructured":"Agarwal A, Rana C. Pigmented dermatofibrosarcoma (Bednar tumour) of scalp. BMJ Case Rep CP. 2023;16:e254473.","journal-title":"BMJ Case Rep CP"},{"key":"1348_CR118","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1100398","volume":"13","author":"Y Li","year":"2023","unstructured":"Li Y, Chen Z, Nie S, Wu Z. Atrophic dermatofibrosarcoma protuberans: two case reports and literature review. Front Oncol. 2023;13: 1100398.","journal-title":"Front Oncol"},{"key":"1348_CR119","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/DSS.0000000000000910","volume":"43","author":"GC Lowe","year":"2017","unstructured":"Lowe GC, Onajin O, Baum CL, Otley CC, Arpey CJ, Roenigk RK, Brewer JD. A comparison of Mohs micrographic surgery and wide local excision for treatment of dermatofibrosarcoma protuberans with long-term follow-up: the Mayo clinic experience. Dermatol Surg. 2017;43:98\u2013106.","journal-title":"Dermatol Surg"},{"key":"1348_CR120","doi-asserted-by":"crossref","unstructured":"Shah P, Trepanowski N, Grant-Kels JM, LeBoeuf M. Mohs micrographic surgery in the surgical treatment paradigm of melanoma in situ and invasive melanoma: A clinical review of treatment efficacy and ongoing controversies. J. Am. Acad. Dermatol; 2024.","DOI":"10.1016\/j.jaad.2024.05.024"},{"key":"1348_CR121","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.ctrv.2008.06.002","volume":"34","author":"A Paradisi","year":"2008","unstructured":"Paradisi A, Abeni D, Rusciani A, Cigna E, Wolter M, Scuderi N, Rusciani L, Kaufmann R, Podda M. Dermatofibrosarcoma protuberans: wide local excision vs. Mohs micrographic surgery. Cancer Treat Rev. 2008;34:728\u201336.","journal-title":"Cancer Treat Rev"},{"key":"1348_CR122","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1016\/j.bjps.2014.05.021","volume":"67","author":"MS Loghdey","year":"2014","unstructured":"Loghdey MS, Varma S, Rajpara SM, Al-Rawi H, Perks G, Perkins W. Mohs micrographic surgery for dermatofibrosarcoma protuberans (DFSP): a single-centre series of 76 patients treated by frozen-section Mohs micrographic surgery with a review of the literature. J Plast Reconstr Aesthet Surg. 2014;67:1315\u201321.","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"1348_CR123","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1001\/archdermatol.2009.140","volume":"145","author":"A Han","year":"2009","unstructured":"Han A, Chen EH, Niedt G, Sherman W, Ratner D. Neoadjuvant imatinib therapy for dermatofibrosarcoma protuberans. Arch Dermatol. 2009;145:792\u20136.","journal-title":"Arch Dermatol"},{"key":"1348_CR124","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.jaad.2010.06.020","volume":"65","author":"B Llombart","year":"2011","unstructured":"Llombart B, Monteagudo C, Sanmart\u00edn O, L\u00f3pez-Guerrero JA, Serra-Guill\u00e9n C, Poveda A, Jorda E, Fernandez-Serra A, Pell\u00edn A, Guill\u00e9n C. Dermatofibrosarcoma protuberans: a clinicopathological, immunohistochemical, genetic (COL1A1-PDGFB), and therapeutic study of low-grade versus high-grade (fibrosarcomatous) tumors. J Am Acad Dermatol. 2011;65:564\u201375.","journal-title":"J Am Acad Dermatol"},{"key":"1348_CR125","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1200\/JCO.2009.25.7899","volume":"28","author":"P Rutkowski","year":"2010","unstructured":"Rutkowski P, Van Glabbeke M, Rankin CJ, Ruka W, Rubin BP, Debiec-Rychter M, Lazar A, Gelderblom H, Sciot R, Lopez-Terrada D. Imatinib mesylate in advanced dermatofibrosarcoma protuberans: pooled analysis of two phase II clinical trials. J Clin Oncol. 2010;28:1772\u20139.","journal-title":"J Clin Oncol"},{"key":"1348_CR126","doi-asserted-by":"publisher","first-page":"3152","DOI":"10.1002\/cncr.25071","volume":"116","author":"W Tong","year":"2010","unstructured":"Tong W, Kantarjian H, O\u2019Brien S, Faderl S, Ravandi F, Borthakur G, Shan J, Pierce S, Rios MB, Cortes J. Imatinib front-line therapy is safe and effective in patients with chronic myelogenous leukemia with pre\u2010existing liver and\/or renal dysfunction. Cancer. 2010;116:3152\u20139.","journal-title":"Cancer"},{"key":"1348_CR127","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1158\/1078-0432.CCR-15-1243","volume":"22","author":"S Stacchiotti","year":"2016","unstructured":"Stacchiotti S, Pantaleo MA, Negri T, Astolfi A, Tazzari M, Dagrada GP, Urbini M, Indio V, Maestro R, Gronchi A. Efficacy and biological activity of Imatinib in metastatic dermatofibrosarcoma protuberans (DFSP). Clin Cancer Res. 2016;22:837\u201346.","journal-title":"Clin Cancer Res"},{"key":"1348_CR128","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.ad.2011.12.005","volume":"103","author":"M Valdivielso-Ramos","year":"2012","unstructured":"Valdivielso-Ramos M, Hernanz J. Dermatofibrosarcoma protuberans En La infancia. Actas Dermosifiliogr. 2012;103:863\u201373.","journal-title":"Actas Dermosifiliogr"},{"key":"1348_CR129","doi-asserted-by":"publisher","DOI":"10.2144\/fsoa-2020-0198","volume":"7","author":"AA Rasheed","year":"2021","unstructured":"Rasheed AA, Barwad A, Dhamija E, Garg R, Pandey R, Shamim SA, Arun Raj ST, Rastogi S. Advanced dermatofibrosarcoma protuberans: an updated analysis of cases from an Indian sarcoma clinic. Future Sci OA. 2021;7: FSO743.","journal-title":"Future Sci OA"},{"key":"1348_CR130","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1158\/1078-0432.CCR-13-1411","volume":"20","author":"S Ugurel","year":"2014","unstructured":"Ugurel S, Mentzel T, Utikal J, Helmbold P, Mohr P, Pf\u00f6hler C, Schiller M, Hauschild A, Hein R, K\u00e4mpgen E. Neoadjuvant imatinib in advanced primary or locally recurrent dermatofibrosarcoma protuberans: a multicenter phase II DeCOG trial with long-term follow-up. Clin Cancer Res. 2014;20:499\u2013510.","journal-title":"Clin Cancer Res"},{"key":"1348_CR131","doi-asserted-by":"publisher","first-page":"224","DOI":"10.5114\/jcb.2023.127807","volume":"15","author":"R Hans","year":"2023","unstructured":"Hans R, Singh S, Arvind P, Sarin A, Semwal MK, Vats P. A case of dermatofibrosarcoma protuberans of the scalp treated with surface mould brachytherapy. J Contemp Brachytherapy. 2023;15:224\u20138.","journal-title":"J Contemp Brachytherapy"},{"key":"1348_CR132","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s00432-009-0550-3","volume":"135","author":"D Lemm","year":"2009","unstructured":"Lemm D, M\u00fcgge L-O, Mentzel T, H\u00f6ffken K. Current treatment options in dermatofibrosarcoma protuberans. J Cancer Res Clin Oncol. 2009;135:653\u201365.","journal-title":"J Cancer Res Clin Oncol"},{"key":"1348_CR133","doi-asserted-by":"publisher","unstructured":"Algarin YA, Pulumati A, Tan J, Zeitouni N. Cutaneous malignancies in people of colour: a review of dermatofibrosarcoma protuberans and Kaposi sarcoma. Curr Dermatol Rep. 2024;13(3):217\u2013225. https:\/\/doi.org\/10.1007\/s13671-024-00432-0.","DOI":"10.1007\/s13671-024-00432-0"},{"key":"1348_CR134","unstructured":"Siddiqui F, Sathe N, Leavitt A. (2024) Mohs Micrographic Surgery Evaluation and Treatment of Dermatofibrosarcoma Protuberans. StatPearls."},{"key":"1348_CR135","unstructured":"Cui L. Near-infrared fluorescence image-guided surgery for malignant soft tissue tumour with low-dose second window indocyanine green technique: multicentre randomised controlled trial. ClinicalTrials.gov identifier NCT06610071; 2024."},{"key":"1348_CR136","unstructured":"ECOG-ACRIN Cancer Research Group. A phase III randomized controlled trial of chest CT vs chest X-Ray for lung surveillance after Curative-Intent resection of High-Risk Truncal-Extremity soft tissue sarcoma. 2024. clinicaltrials.gov."},{"key":"1348_CR137","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1111\/j.1524-4725.2012.02482.x","volume":"38","author":"P Kuzel","year":"2012","unstructured":"Kuzel P, Metelitsa AI, Dover DC, Salopek TG. Epidemiology of dermatofibrosarcoma protuberans in Alberta, Canada, from 1988 to 2007. Dermatol Surg. 2012;38:1461\u20138.","journal-title":"Dermatol Surg"},{"key":"1348_CR138","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.5858\/arpa.2016-0598-RA","volume":"141","author":"H Yang","year":"2017","unstructured":"Yang H, Yu L. Cutaneous and superficial soft tissue CD34\u2009+\u2009spindle cell proliferation. Arch Pathol Lab Med. 2017;141:1092\u2013100.","journal-title":"Arch Pathol Lab Med"},{"key":"1348_CR139","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.humpath.2007.06.009","volume":"39","author":"KU Patel","year":"2008","unstructured":"Patel KU, Szabo SS, Hernandez VS, Prieto VG, Abruzzo LV, Lazar AJ, L\u00f3pez-Terrada D. Dermatofibrosarcoma protuberans COL1A1-PDGFB fusion is identified in virtually all dermatofibrosarcoma protuberans cases when investigated by newly developed multiplex reverse transcription polymerase chain reaction and fluorescence in situ hybridization assays. Hum Pathol. 2008;39:184\u201393.","journal-title":"Hum Pathol"},{"key":"1348_CR140","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3109\/23320885.2014.995185","volume":"2","author":"K-T Chiang","year":"2015","unstructured":"Chiang K-T, Lee S-Y, Chu H. Dermatofibrosarcoma protuberans, a rare but locally aggressive tumor on finger: clinical and aeromedical considerations. Case Rep Plast Surg Hand Surg. 2015;2:15\u20138.","journal-title":"Case Rep Plast Surg Hand Surg"},{"key":"1348_CR141","doi-asserted-by":"publisher","first-page":"166","DOI":"10.4081\/rt.2015.5981","volume":"7","author":"AC Lorduy","year":"2015","unstructured":"Lorduy AC, Obispo B, Villar K, Buchser D, Rogado J, de la Maza MDF, Alfranca YL, Colomer R. Dermatofibrosarcoma protu-berans with lung metastasis requiring pneumonectomy. Rare Tumors. 2015;7:166\u20138.","journal-title":"Rare Tumors"},{"key":"1348_CR142","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.bjps.2022.11.002","volume":"77","author":"ZG G\u00fc\u00e7","year":"2023","unstructured":"G\u00fc\u00e7 ZG, G\u00fc\u00e7 H, B\u00fct\u00fcn O, Alacac\u0131o\u011flu A, Demird\u00f6ver C. Oncological efficiency of wide local excision in dermatofibrosarcoma protuberans. J Plast Reconstr Aesthet Surg. 2023;77:244\u201352.","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"1348_CR143","doi-asserted-by":"crossref","unstructured":"Meguerditchian A-N, Wang J, Lema B, Kraybill WG, Zeitouni NC, Kane JM III. Wide excision or Mohs micrographic surgery for the treatment of primary dermatofibrosarcoma protuberans. Am J Clin Oncol. 2010;33:300\u20133.","DOI":"10.1097\/COC.0b013e3181aaca87"},{"key":"1348_CR144","doi-asserted-by":"publisher","unstructured":"Khan S, Yetiskul E, Niazi M, Khan MWZ, Pokima N, Khattar G, Terjanian T, Khattar G. Metastatic fibrosarcomatous transformation of dermatofibrosarcoma protuberans with lung metastasis: a case report. Cureus. 2024;16(5):e59742. https:\/\/doi.org\/10.7759\/cureus.59742.","DOI":"10.7759\/cureus.59742"},{"key":"1348_CR145","doi-asserted-by":"crossref","unstructured":"Bordeaux J, Blitzblau R, Aasi SZ, Alam M, Amini A, Bibee K, Bolotin D, Chen P-L, Contreras CM, DiMaio D. Dermatofibrosarcoma Protuberans, Version 1.2025, NCCN Clinical Practice Guidelines In Oncology. J Natl Compr Canc Netw. 2025;23.","DOI":"10.6004\/jnccn.2025.0001"}],"container-title":["Current Treatment Options in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-025-01348-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11864-025-01348-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-025-01348-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T08:03:38Z","timestamp":1761293018000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11864-025-01348-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,3]]},"references-count":145,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["1348"],"URL":"https:\/\/doi.org\/10.1007\/s11864-025-01348-y","relation":{},"ISSN":["1527-2729","1534-6277"],"issn-type":[{"value":"1527-2729","type":"print"},{"value":"1534-6277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,3]]},"assertion":[{"value":"24 July 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}